36142465|t|Targeting PSEN1 by lnc-CYP3A43-2/miR-29b-2-5p to Reduce beta Amyloid Plaque Formation and Improve Cognition Function.
36142465|a|Presenilin-1 (PSEN1) is a crucial subunit within the gamma-secretase complex and regulates beta-amyloid (Abeta) production. Accumulated evidence indicates that n-butylidenephthalide (BP) acts effectively to reduce Abeta levels in neuronal cells that are derived from trisomy 21 (Ts21) induced pluripotent stem cells (iPSCs). However, the mechanism underlying this effect remains unclear. This article aims to investigate the possible mechanisms through which BP ameliorates the development of Alzheimer's disease (AD) and verify the effectiveness of BP through animal experiments. Results from RNA microarray analysis showed that BP treatment in Ts21 iPSC-derived neuronal cells reduced long noncoding RNA (lncRNA) CYP3A43-2 levels and increased microRNA (miR)-29b-2-5p levels. Bioinformatics tool prediction analysis, biotin-labeled miR-29b-2-5p pull-down assay, and dual-luciferase reporter assay confirmed a direct negative regulatory effect for miRNA29b-2-5p on lnc-RNA-CYP3A43-2 and PSEN1. Moreover, BP administration improved short-term memory and significantly reduced Abeta accumulation in the hippocampus and cortex of 3xTg-AD mice but failed in miR-29b-2-5p mutant mice generated by CRISP/Cas9 technology. In addition, analysis of brain samples from patients with AD showed a decrease in microRNA-29b-2-5p expression in the frontal cortex region. Our results provide evidence that the LncCYP3A43-2/miR29-2-5p/PSEN1 network might be involved in the molecular mechanisms underlying BP-induced Abeta reduction.
36142465	10	15	PSEN1	Gene	19164
36142465	118	130	Presenilin-1	Gene	5663
36142465	132	137	PSEN1	Gene	5663
36142465	223	228	Abeta	Gene	351
36142465	278	299	n-butylidenephthalide	Chemical	MESH:C026105
36142465	301	303	BP	Chemical	MESH:C026105
36142465	332	337	Abeta	Gene	351
36142465	385	395	trisomy 21	Disease	MESH:D004314
36142465	397	401	Ts21	Disease	MESH:D004314
36142465	577	579	BP	Chemical	MESH:C026105
36142465	611	630	Alzheimer's disease	Disease	MESH:D000544
36142465	632	634	AD	Disease	MESH:D000544
36142465	668	670	BP	Chemical	MESH:C026105
36142465	748	750	BP	Chemical	MESH:C026105
36142465	764	768	Ts21	CellLine	CVCL:VF04
36142465	873	884	(miR)-29b-2	Gene	723963
36142465	937	943	biotin	Chemical	MESH:D001710
36142465	1106	1111	PSEN1	Gene	19164
36142465	1123	1125	BP	Chemical	MESH:C026105
36142465	1194	1199	Abeta	Gene	11820
36142465	1251	1253	AD	Disease	MESH:D000544
36142465	1254	1258	mice	Species	10090
36142465	1293	1297	mice	Species	10090
36142465	1378	1386	patients	Species	9606
36142465	1392	1394	AD	Disease	MESH:D000544
36142465	1416	1430	microRNA-29b-2	Gene	407025
36142465	1526	1533	miR29-2	Gene	100049711
36142465	1537	1542	PSEN1	Gene	19164
36142465	1608	1610	BP	Chemical	MESH:C026105
36142465	1619	1624	Abeta	Gene	351
36142465	Association	MESH:C026105	19164
36142465	Association	351	5663
36142465	Association	MESH:C026105	100049711
36142465	Association	100049711	351
36142465	Association	19164	351
36142465	Negative_Correlation	MESH:C026105	MESH:D004314
36142465	Negative_Correlation	MESH:C026105	MESH:D000544
36142465	Negative_Correlation	MESH:C026105	351
36142465	Positive_Correlation	MESH:C026105	723963
36142465	Negative_Correlation	MESH:C026105	11820
36142465	Negative_Correlation	MESH:D000544	407025

